A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
NCT ID: NCT00241449
Last Updated: 2012-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
51 participants
INTERVENTIONAL
1998-11-30
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
NCT00274469
Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer
NCT00259090
Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors
NCT00253422
Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
NCT00328120
Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
NCT00099437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Tamoxifen
Tamoxifen
20 mg oral tablet
2
Fulvestrant
Fulvestrant
intramuscular injection 250 mg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fulvestrant
intramuscular injection 250 mg
Tamoxifen
20 mg oral tablet
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Postmenopausal women. Written informed consent to participate in the study.
Exclusion Criteria
Previous treatment with Faslodex. Any existing serious disease, illness, or condition that will prevent participation or compliance with the study procedures.
Treatment with an investigational or non-approved drug within one month of then start of the study.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca Oncology Medical Science Director, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Little Rock, Arkansas, United States
Research Site
Fountain Valley, California, United States
Research Site
La Jolla, California, United States
Research Site
Orange, California, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Venice, Florida, United States
Research Site
Decatur, Georgia, United States
Research Site
Chicago, Illinois, United States
Research Site
Mason City, Iowa, United States
Research Site
Shreveport, Louisiana, United States
Research Site
Gloucester, Massachusetts, United States
Research Site
Detroit, Michigan, United States
Research Site
Voorhees Township, New Jersey, United States
Research Site
Columbus, Ohio, United States
Research Site
Meadowbrook, Pennsylvania, United States
Research Site
Providence, Rhode Island, United States
Research Site
Austin, Texas, United States
Research Site
Galveston, Texas, United States
Research Site
Houston, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
Temple, Texas, United States
Research Site
Richmond, Virginia, United States
Research Site
Lacey, Washington, United States
Research Site
Seattle, Washington, United States
Research Site
Buenos Aires, , Argentina
Research Site
Rosario, , Argentina
Research Site
Camperdown, , Australia
Research Site
Concord, , Australia
Research Site
Heidelburg, , Australia
Research Site
Melbourne, , Australia
Research Site
Salzburg, , Austria
Research Site
Vienna, , Austria
Research Site
Antwerp, , Belgium
Research Site
Haine-Saint-Paul, , Belgium
Research Site
Hasselt, , Belgium
Research Site
Leuven, , Belgium
Research Site
Belo Horizonte, , Brazil
Research Site
Goiânia, , Brazil
Research Site
São Paulo, , Brazil
Research Site
Edmonton, Alberta, Canada
Research Site
Penticton, British Columbia, Canada
Research Site
Saint John, New Brunswick, Canada
Research Site
Newmarket, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Weston, Ontario, Canada
Research Site
York, Ontario, Canada
Research Site
Chicoutimi, , Canada
Research Site
Montreal, , Canada
Research Site
Kotka, , Finland
Research Site
Kuopio, , Finland
Research Site
Rovaniemi, , Finland
Research Site
Clermont-Ferrand, , France
Research Site
Évreux, , France
Research Site
Lyon, , France
Research Site
Montpellier, , France
Research Site
Pierre-Bénite, , France
Research Site
Rodez, , France
Research Site
Rouen, , France
Research Site
Tours, , France
Research Site
Frankfurt, , Germany
Research Site
Göttingen, , Germany
Research Site
Rostock, , Germany
Research Site
Budapest, , Hungary
Research Site
Pécs, , Hungary
Research Site
Székesfehérvár, , Hungary
Research Site
Szolnok, , Hungary
Research Site
Dublin, , Ireland
Research Site
Ashkelon, , Israel
Research Site
Haifa, , Israel
Research Site
Bologna, , Italy
Research Site
Brescia, , Italy
Research Site
Forlì, , Italy
Research Site
Genova, , Italy
Research Site
Milan, , Italy
Research Site
Napoli, , Italy
Research Site
Palermo, , Italy
Research Site
Perugia, , Italy
Research Site
Pisa, , Italy
Research Site
Reggio Calabria, , Italy
Research Site
Reggio Emilia, , Italy
Research Site
Rozzano, , Italy
Research Site
Sassari, , Italy
Research Site
Trieste, , Italy
Research Site
Amagasaki, , Japan
Research Site
Fukuoka, , Japan
Research Site
Kitakyushu, , Japan
Research Site
Kumamoto, , Japan
Research Site
Matsuyama, , Japan
Research Site
Nagoya, , Japan
Research Site
Niigata, , Japan
Research Site
Osaka, , Japan
Research Site
Ōita, , Japan
Research Site
Saitama, , Japan
Research Site
Sapporo, , Japan
Research Site
Suita, , Japan
Research Site
Tokyo, , Japan
Research Site
Guadalajara, , Mexico
Research Site
Mexico City, , Mexico
Research Site
The Hague, , Netherlands
Research Site
Christchurch, , New Zealand
Research Site
Palmerston North, , New Zealand
Research Site
Bydgoszcz, , Poland
Research Site
Krakow, , Poland
Research Site
Szczecin, , Poland
Research Site
Warsaw, , Poland
Research Site
Coimbra, , Portugal
Research Site
Moscow, , Russia
Research Site
Cape Town, , South Africa
Research Site
Johannesburg, , South Africa
Research Site
Lyttelton Manor, , South Africa
Research Site
Badalona, , Spain
Research Site
Guadalajara, , Spain
Research Site
Madrid, , Spain
Research Site
Málaga, , Spain
Research Site
Kaohsiung City, , Taiwan
Research Site
Taichung, , Taiwan
Research Site
Tainan City, , Taiwan
Research Site
Taipei, , Taiwan
Research Site
Taoyuan District, , Taiwan
Research Site
Istanbul, , Turkey (Türkiye)
Research Site
Belfast, , United Kingdom
Research Site
Birmingham, , United Kingdom
Research Site
Chelmsford, , United Kingdom
Research Site
Chorley, , United Kingdom
Research Site
Coventry, , United Kingdom
Research Site
Huddersfield, , United Kingdom
Research Site
Leeds, , United Kingdom
Research Site
London, , United Kingdom
Research Site
Luton, , United Kingdom
Research Site
Manchester, , United Kingdom
Research Site
Newcastle upon Tyne, , United Kingdom
Research Site
Northampton, , United Kingdom
Research Site
Nottingham, , United Kingdom
Research Site
Prescot, , United Kingdom
Research Site
Telford, , United Kingdom
Research Site
Whitehaven, , United Kingdom
Research Site
Worthing, , United Kingdom
Research Site
York, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9238IL/0025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.